April 7, 2014

Low-Dose Aspirin for Prevention of Morbidity and Mortality From Preeclampsia: A Systematic Evidence Review for the U.S. Preventive Services Task Force

Structured PICO

Does daily low-dose aspirin prevent morbidity and mortality from preeclampsia?

P

Population

Individuals at risk for morbidity and mortality from preeclampsia

I

Intervention

Daily low-dose aspirin beginning as early as the second trimester

O

Outcome

Morbidity and mortality from preeclampsiahard clinical

Daily low-dose aspirin starting in the second trimester prevents clinically important health outcomes related to preeclampsia without identified harms.

Abstract

Daily low-dose aspirin beginning as early as the second trimester prevented clinically important health outcomes. No harms were identified, but long-term evidence was limited.

Low-Dose Aspirin for Prevention of Morbidity and Mortality From Preeclampsia: A Systematic Evidence Review for the U.S. Preventive Services Task Force

Structured PICO

Abstract

Cite This Study